tiprankstipranks
Trending News
More News >
Krystal Biotech (KRYS)
NASDAQ:KRYS

Compare Krystal Biotech (KRYS) vs. Competitors

Compare
606 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Krystal Biotech
$252.17
$7.31B
37.82
57.80%
8 Buy
1 Hold
0 Sell
Strong Buy
Alkermes
$28.49
$4.70B
14.10
-1.01%
11 Buy
4 Hold
0 Sell
Moderate Buy
PTC Therapeutics
$78.56
$6.31B
9.18
71.64%
8 Buy
5 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$55.08
$5.25B
-9.87
42.51%
12 Buy
7 Hold
0 Sell
Moderate Buy
MoonLake Immunotherapeutics
$13.83
$987.10M
-4.16
-73.92%
10 Buy
4 Hold
2 Sell
Moderate Buy
Arcellx Inc
$65.71
$3.80B
-16.77
-16.13%
16 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KRYS
Krystal Biotech
252.17
92.37
57.80%
ALKS
Alkermes
28.49
-0.29
-1.01%
PTCT
PTC Therapeutics
78.56
32.79
71.64%
CRSP
Crispr Therapeutics AG
55.08
16.43
42.51%
MLTX
MoonLake Immunotherapeutics
13.83
-39.19
-73.92%
ACLX
Arcellx Inc
65.71
-12.64
-16.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts